US Stem Cell Market Poised for Growth

The positive response of people towards stem cell technology and the lifting-up of ban on embryonic stem cell research will fuel the growth of the US stem cell market in future.

Delhi, India, June 05, 2009 --( The stem cell market in US is expected to grow at a CAGR of 84% during 2009-2012 to reach at around US$ 889 Million by 2012, says a new report “US Stem Cell Market Analysis” from RNCOS.

The optimistic approach of the patients suffering from severe diseases towards the adoption of stem cell technology will fuel the growth of the stem cell market in future. Also, the rise in healthcare spending, with large part of the population without any health insurance cover, is making the costly treatments unfavorable for the Americans.

The US soon realized the hidden potential in stem cell market and took timely moves to ensure stem-cell storage that led to the development of therapeutic banking technology segment. The country therefore is backed up with adequate infrastructure to support the use of stem cells for therapy and research purposes.

The country has achieved some important milestones in the therapy areas like bone marrow transplantation with the help of stem cell technology. The cellular therapeutics though smaller in size than therapeutics banking market is expected to grow comparatively fast during 2009-2012.

The US stem cell market presently has few orthopedic products. However, seeing its efficacy to cure a problem over the present available treatments, researches are going on to find out new therapeutic applications.

The market is also expected to witness a robust growth with the easing-off of the regulatory constraints and federal funding in 21 different embryonic stem cell lines. The embryonic stem cells have the ability to convert into different types of tissues in the body and thus, they exhibit higher potential to cure a disease.

Their report “US Stem Cell Market Analysis” provides the rational analysis and extensive research on the stem cell market in the US. The report thoroughly examines the current industry trends which are adding to the growth in the country’s stem cell market. The report also highlights various emerging therapy segments and their market potential to serve the population of the country more effectively.

For Free Sample of this report visit:

Check Discounted Reports on:

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Shushmul Maheshwari
Chief Executive
29, 1st Floor, Patparganj Industrial Area, Delhi 92